Pharmafile Logo

Leveraging virtual tools to get the most out of hybrid congresses

Tips on how to optimize congress information-gathering…

The COVID-19 pandemic turned virtual congresses from a relatively rare occurrence to a must-have in 2020. While we saw some attempts at hybrid and in-person events in 2021, 2022 was the year that hybrid congresses and conferences finally became a mainstay across the medical and scientific communities. Although this format adds a layer of complexity for the organizers, it’s a win-win situation for presenters and attendees alike. I could dedicate an entire separate article to the benefits of hybrid congresses for the environment, attendee convenience, and budget alone!

With the shift to hybrid conferences, you can now watch sessions you missed on-demand and visit all posters on your own time. However, the large amount of data being presented and multiple simultaneous sessions can make it hard to focus the attendees’ attention. As a result, it becomes difficult to gather targeted feedback. For Pharma, getting all of their key opinion leaders (KOLs) in one room to get their thoughts on the new data presented during the congress can often prove difficult due to scheduling conflicts or some KOLs attending the conference virtually. Other healthcare providers (HCPs) may not attend at all due to time or financial constraints.

If you, like many other life science leaders, are struggling with coordinating, documenting, following up on, and disseminating clear, relevant insights from congresses, access the rest of this article for my tips on how to optimize congress information-gathering.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Effective Communication in Virtual Meetings: Stay Pithy – Impetus InSite Tips #4

Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today's fast-paced...

Enhancing Honesty in Feedback: Blinded Questions

Explore our third tip in our series aimed at refining asynchronous virtual meetings. Discover how using blinded questions can significantly minimize bias and enhance the integrity of feedback in virtual...

Streamlining Asynchronous Feedback: Scale Consistency – Impetus InSite Tips #2

Uncover the second crucial tip for optimizing your asynchronous virtual meetings. Learn the importance of scale consistency in survey-style questions on the Impetus InSite Platform to ensure clear and reliable...

Clinical Trial Protocol Conceptualization: A Customer Story

To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical...

Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...